Abstract
The compulsive behaviors seen in sexualparaphilias may be related to those ofobsessive-compulsive disorder (OCD). Based primarilyupon case reports as well as studies indicating theeffectiveness of serotonin reuptake inhibitors in the treatment of sexualparaphilias, it has been speculated that sexualparaphilias lie within the obsessive-compulsivespectrum. There have been no reports of the use ofparoxetine in the treatment of sexual paraphilias. This isa report of two patients, the first a voyeur and thesecond an exhibitionist, both of whom responded totreatment with paroxetine. The discussion addresses the need for further comparative studiesinvestigating the role of the serotonin system in thepathogenesis of sexual paraphilias and OCD as well asthe effect of serotonin reuptake inhibitors incomparison to other pharmacologic modalities used in thetreatment of paraphilias.
Similar content being viewed by others
REFERENCES
Barr, L. C., Goodman, W. K., Price, L. H., McDougle, C. J., and Charney,D S. The serotonin hypothesis of obsessive-compulsive disorder: Implications of pharmacologic challenge studies. J. Clin. Psychiat. 53(4, Suppl.): 17-28.
Baxter, L. R., Schwartz, J. M., Bergman, K. S., Szuba, M. P., Guze, B. H., Mazziotta, J. C., Alazraki, A., Selin, C. E., Ferng, H., Munford, P., and Phelps, M. E. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive compulsive disorder. Arch. Gen. Psychiat. 49: 681-689.
Behar, D., Rapoport, J. L., Berg, C. J. (1984). Computerized tomography and neuropsychological measures in adolescents with obsessive-compulsive disorder. Am. J. Psychiat. 141: 363-369.
Bradford, J. M. W. (1995). Pharmacologic Treatment of the Paraphilias, In Oldham, J. M., and Riba, M. B. (eds.), American Psychiatric Press Review of Psychiatry, Vol. 14, American Psychiatric Press, Washington, DC.
Chouinard, R., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., White, K., Hackett, E., Gaffney, M., and Bick, P. A. (1990). Results of a double blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive compulsive disorder. Psychopharm acol. Bull. 26: 279-284.
Clompipramine Collaborative Study Group. (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch. Gen. Psychiat. 48: 730-738.
Clayton, A. H. (1993). Fetishism and Clomipramine. Am. J. Psychiat. 150: 673-674.
Gessa, G. L., Tagliamonte, A., and Brodie, B. B. (1970). Essentail role ot testosterone on the sexual stimulation induced by p-Chlorophenylalanine in male animals. Nature 227: 616-617.
Gitlin, M. J. (1994). Psychotropic medication and their effects on sexual function: Diagnosis, biology and treatment approaches. J. Clin. Psychiat. 55: 406-413.
Greenburg, D. M., and Bradford, J. M. W. (1997). Treatment of the paraphilia disorders: A review of the role of the selective serotonin reuptake inhibitors. Sexual abuse: J. Res. Treat. 9: 349-360.
Greenburg D. M., Bradford, J. M. W., Curry S., and O'Rourke, A. B. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study. Am Acad. Psychiat. Law, 24: 525-532.
Jacobsen, F. M. (1992). Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J. Clin. Psychiat. 53: 119-122.
Jenike, M. A., Hyman, S., Baer, L., Holland, A., Minichiello, W. E., Buttolph, L., Summergrad, P., Seymour, R., and Ricciardi, J. (1990). A controlled trial of fluvoxamine in obsessive-compulsive disorder. Am. J. Psychiat. 147: 1209-1215.
Kafka, M. P. (1991). Successful antidepressant treatment of non-paraphilic sexual addictions and paraphilias in men. J. Clin. Psychiat. 52: 60-65.
Kafka, M. P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia related disorders. An open trial. Ann. Clin. Psychiat. 6: 189-195.
Kafka, M. P., and Prentky, R. (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J. Clin. Psychiat. 53: 351-358.
Lucey, J. V., Butcher, G., Clare, A. W., and Dinan, T. G. (1993). The anterior pituitary responds normally to protirelin in obsessive-compulsive disorde r: Evidence to support a neuroendocrine serotonergic deficit. Acta Psychiat. Scand. 87: 384-388.
Marazitti, D., Hollander, E., Lensi, P., Ravagli, S., and Cassano, G. B. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder. Psychiat. Res. 42: 41-51.
Perilstein, R. D., Lipper, S., and Freidman, L. J. Three cases of pedophilia responsive to fluoxetine treatment. J. Clin. Psychiat. 52: 169-170.
Rapoport, J., Wise, S., Lauffer, M., Munitz, H. (1988). Obsessive-compulsive disorder: A basal ganglia disease? In Rapoport, J. (e d.), Obsessive Compulsive Disorder in Children and Adolescents, APPI Press, Washington, DC: pp. 327-344.
Risch, C. S., and Nemeroff, C. B. (1992). Neurochemical alteration of serotonergic neuronal systems in depression. J. Clin. Psychiat. 53(10, Suppl.).
Swedo S. E., Pietrini, P., Leonard, H. L., Schapiro, M. B., Rettew, D. C., Goldberger, E. L., Rapoport, S. I., Rapoport, J. L., and Grady, C. L. (1992). Cerebral glucose metabolism in childhood onset obsessive compulsive disorder: Revisualization during pharmacotherapy. Arch. Gen. Psychiat. 49: 690-694.
Stein, D. J., Hollander, E, Anthony, D. T., Scheier, F. R., Fallon, B. A., Liebowitz, M. R., and Klein, D. F. (1992). Serotonergic medications for sexual obsessions, sexual addictions and paraphilias. J. Clin. Psychiat. 53: 267-271.
Tagliamonte, A., Tagliamonte, P., Gessa, G. L., and Brodie, B. B. (1969). Compulsive sexual activity induced by p-Chlorophenylalanine in normal and pinealectomized male rats. Science 166: 1433-1435.
Tollefson, G. D., Rampey, A. H., Potvin, J. H., Jenike, M. A., Rush, A. J., Dominguez, R. A., Koran, L. M., Shear, M. K., Goodman, W., and Grenduso, L. A. (1994). A multicenter investigation of fixed dose fluoxetine in the treatment of obsessive compulsive disorder. Arch. Gen. Psychiat. 51: 559-567.
Zajecka, J., Fawcett, J., Schaff, M., Jeffriess, H., and Guy, C. (1991). The role of serotonin in sexual dysfunction: Fluoxetine associated dysfunction. J. Clin. Psychiat. 52: 66-68.
Zohar, J., and Judge, R. (1996). Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxe tine study investigators. Br. J. Psychiat. 169: 468-474.
Zohar, J., Klein, E. M., Maeller, A., Insel, T. R., Uhde, T. W., Murphy, D. L. (1987). 5-HT, obsessive-compulsive disorder and anxiety. In Proceedings of the Ame rican Psychiatric Association, Chicago, p. 175.
Rights and permissions
About this article
Cite this article
Abouesh, A., Clayton, A. Compulsive Voyeurism and Exhibitionism: A Clinical Response to Paroxetine. Arch Sex Behav 28, 23–30 (1999). https://doi.org/10.1023/A:1018737504537
Issue Date:
DOI: https://doi.org/10.1023/A:1018737504537